Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Kangyuan Yangguang Pharmaceutical is a key subsidiary of Kanion Pharmaceutical, a leading Chinese pharmaceutical company specializing in the modernization of Traditional Chinese Medicine (TCM). The company focuses on the research, development, and commercialization of innovative TCM and chemical drugs across several therapeutic areas, including cardiovascular, gynecological, and respiratory health. It leverages advanced manufacturing and R&D capabilities to bridge traditional herbal medicine with modern clinical standards. Based in Lianyungang, the company plays a vital role in the group's strategy to integrate traditional wisdom with cutting-edge biotechnology. Its portfolio includes well-known products such as the Guizhi Fuling Capsule and Re-Du-Ning Injection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Kangyuan Yangguang Pharmaceutical.